SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3/A - Initial statement of beneficial ownership of securities: [Amend]
SEC Accession No. 0001104659-23-081674
Filing Date
2023-07-17
Accepted
2023-07-17 17:03:07
Documents
1
Period of Report
2023-07-13

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2321456-5_3aseq1.html 3/A  
1 OWNERSHIP DOCUMENT tm2321456-5_3aseq1.xml 3/A 2850
  Complete submission text file 0001104659-23-081674.txt   4401
Mailing Address C/O NUVATION BIO INC. 1500 BROADWAY, SUITE 1401 NEW YORK NY 10036
Business Address
Fox Jennifer A. (Reporting) CIK: 0001841557 (see all company filings)

Type: 3/A | Act: 34 | File No.: 001-41740 | Film No.: 231092249

Mailing Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453
Business Address 221 CRESCENT ST. BUILDING 17, SUITE 102B WALTHAM MA 02453 650-394-5230
Apogee Therapeutics, Inc. (Issuer) CIK: 0001974640 (see all company filings)

IRS No.: 880588063 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)